A detailed history of Significant Wealth Partners LLC transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Significant Wealth Partners LLC holds 15,132 shares of VKTX stock, worth $602,253. This represents 0.19% of its overall portfolio holdings.

Number of Shares
15,132
Previous 13,066 15.81%
Holding current value
$602,253
Previous $346 Million 14.85%
% of portfolio
0.19%
Previous 0.17%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 03, 2025

BUY
$23.09 - $42.09 $47,703 - $86,957
2,066 Added 15.81%
15,132 $398 Million
Q2 2025

Jul 15, 2025

BUY
$19.98 - $29.49 $81,378 - $120,112
4,073 Added 45.29%
13,066 $346 Million
Q1 2025

Apr 30, 2025

BUY
$24.15 - $42.89 $86,843 - $154,232
3,596 Added 66.63%
8,993 $217 Million
Q4 2024

Feb 11, 2025

BUY
$38.28 - $78.03 $206,597 - $421,127
5,397 New
5,397 $217 Million

Others Institutions Holding VKTX

About Viking Therapeutics, Inc.


  • Ticker VKTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,688,496
  • Market Cap $3.05B
  • Description
  • Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...
More about VKTX
Track This Portfolio

Track Significant Wealth Partners LLC Portfolio

Follow Significant Wealth Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Significant Wealth Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Significant Wealth Partners LLC with notifications on news.